Healthcare • Drug Manufacturers - Specialty & Generic
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ETON is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
35 top institutions tracked
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 8 days ago
Red flags: 2
165 filers reported a long position in ETON for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Opaleye Management Inc. | $103.5M | 2.9M | Unchanged |
| EcoR1 Capital, LLC | $78.6M | 2.2M | Unchanged |
| BlackRock, Inc. | $68.6M | 1.9M | +10.4% |
| Nantahala Capital Management, LLC | $42.6M | 1.2M | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $35.4M | 976.6K | -1.8% |
| MORGAN STANLEY | $27.8M | 768K | +60.7% |
| STATE STREET CORP | $25.4M | 701.8K | +32.4% |
| GEODE CAPITAL MANAGEMENT, LLC | $23.6M | 652.3K | +12.9% |
| OBERWEIS ASSET MANAGEMENT INC/ | $18.2M | 501.6K | +14.2% |
| National Philanthropic Trust | $17.8M | 492.1K | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.